04/08/2025
Innovation has always been the foundation of progress, but how we innovate matters as much as the results we achieve.
Recent breakthroughs in aerospace and artificial intelligence prove that massive budgets don’t drive innovation, but efficiency, speed and a relentless commitment to doing more with less do. Success comes from embracing resourcefulness as a strategic advantage, fueled by deep passion and bold thinking. Yet, the biotech industry has been slow to adopt this mindset. It’s time to rethink how we innovate in this field, prioritizing agility, smart investment and transformative ideas over outdated, costly models.
CLICK HERE to read Dr. Gabi Hanna’s full column in The Washington Times.